Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3571 | 1879 | 52.6 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VIRUS CELL INTERACT SECT | Address | 59 | 69% | 3% | 50 |
| 2 | GAG | Author keyword | 36 | 28% | 6% | 109 |
| 3 | M PMV | Author keyword | 32 | 85% | 1% | 17 |
| 4 | HIV DRUG ISTANCE PROGRAM | Address | 15 | 15% | 5% | 88 |
| 5 | VIROLOGICAL SYNAPSE | Author keyword | 13 | 49% | 1% | 20 |
| 6 | HIV ASSEMBLY | Author keyword | 9 | 83% | 0% | 5 |
| 7 | RETROVIRAL ASSEMBLY | Author keyword | 9 | 83% | 0% | 5 |
| 8 | RETROVIRUS ASSEMBLY | Author keyword | 8 | 60% | 0% | 9 |
| 9 | ENVELOPE INCORPORATION | Author keyword | 8 | 100% | 0% | 5 |
| 10 | CAPSID | Author keyword | 8 | 16% | 3% | 47 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GAG | 36 | 28% | 6% | 109 | Search GAG | Search GAG |
| 2 | M PMV | 32 | 85% | 1% | 17 | Search M+PMV | Search M+PMV |
| 3 | VIROLOGICAL SYNAPSE | 13 | 49% | 1% | 20 | Search VIROLOGICAL+SYNAPSE | Search VIROLOGICAL+SYNAPSE |
| 4 | HIV ASSEMBLY | 9 | 83% | 0% | 5 | Search HIV+ASSEMBLY | Search HIV+ASSEMBLY |
| 5 | RETROVIRAL ASSEMBLY | 9 | 83% | 0% | 5 | Search RETROVIRAL+ASSEMBLY | Search RETROVIRAL+ASSEMBLY |
| 6 | RETROVIRUS ASSEMBLY | 8 | 60% | 0% | 9 | Search RETROVIRUS+ASSEMBLY | Search RETROVIRUS+ASSEMBLY |
| 7 | ENVELOPE INCORPORATION | 8 | 100% | 0% | 5 | Search ENVELOPE+INCORPORATION | Search ENVELOPE+INCORPORATION |
| 8 | CAPSID | 8 | 16% | 3% | 47 | Search CAPSID | Search CAPSID |
| 9 | CAPSID ASSEMBLY INHIBITOR | 6 | 80% | 0% | 4 | Search CAPSID+ASSEMBLY+INHIBITOR | Search CAPSID+ASSEMBLY+INHIBITOR |
| 10 | P17 MATRIX PROTEIN | 6 | 80% | 0% | 4 | Search P17+MATRIX+PROTEIN | Search P17+MATRIX+PROTEIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GP41 CYTOPLASMIC TAIL | 133 | 83% | 4% | 76 |
| 2 | TYPE 1 MATRIX PROTEIN | 103 | 85% | 3% | 55 |
| 3 | BACULOVIRUS INFECTED CELLS | 98 | 84% | 3% | 53 |
| 4 | TYPE 1 MATRIX | 86 | 84% | 3% | 47 |
| 5 | NUCLEOCAPSID DOMAIN | 81 | 96% | 1% | 25 |
| 6 | MAJOR HOMOLOGY REGION | 80 | 70% | 4% | 66 |
| 7 | HIV 1 GAG | 58 | 54% | 4% | 74 |
| 8 | GAG PROTEIN | 50 | 39% | 5% | 101 |
| 9 | HIV 1 CAPSID PROTEIN | 49 | 57% | 3% | 58 |
| 10 | TYPE 1 GAG PROTEIN | 49 | 82% | 1% | 28 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The structural biology of HIV assembly | 2008 | 210 | 140 | 75% |
| The Molecular Architecture of HIV | 2011 | 51 | 53 | 83% |
| HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation | 2011 | 88 | 297 | 50% |
| The roles of lipids and nucleic acids in HIV-1 assembly | 2014 | 6 | 146 | 75% |
| Molecular Determinants that Regulate Plasma Membrane Association of HIV-1 Gag | 2011 | 34 | 114 | 82% |
| Functional surfaces of the human immunodeficiency virus type 1 capsid protein | 2003 | 216 | 98 | 81% |
| HIV Gag polyprotein: processing and early viral particle assembly | 2013 | 26 | 92 | 53% |
| The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41 | 2013 | 24 | 203 | 53% |
| HIV-1 Gag proteins: Diverse functions in the virus life cycle | 1998 | 391 | 156 | 53% |
| Membrane interaction of retroviral Gag proteins | 2014 | 4 | 86 | 67% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VIRUS CELL INTERACT SECT | 59 | 69% | 2.7% | 50 |
| 2 | HIV DRUG ISTANCE PROGRAM | 15 | 15% | 4.7% | 88 |
| 3 | EQUIPE RETROVIRUS TRANSFERT GEN | 4 | 75% | 0.2% | 3 |
| 4 | SERV INMUNOBIOL MOL | 3 | 60% | 0.2% | 3 |
| 5 | HIV 1 RNA TRAFFICKING | 2 | 67% | 0.1% | 2 |
| 6 | CEVAN | 2 | 25% | 0.3% | 6 |
| 7 | TECHNOL PROGRAM | 2 | 14% | 0.5% | 10 |
| 8 | ANTIVIRAL BIOL | 1 | 50% | 0.1% | 2 |
| 9 | CALS | 1 | 16% | 0.3% | 6 |
| 10 | SECT EXPT ONCOL IMMUNOL | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000163746 | RNA DIMERIZATION//NCP7//HIV 1 NUCLEOCAPSID PROTEIN |
| 2 | 0.0000145783 | ESCRT//ALG 2//TSG101 |
| 3 | 0.0000132553 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
| 4 | 0.0000126345 | VPU//BST 2//TETHERIN |
| 5 | 0.0000100455 | GENE THER Y S//PATHOTROPIC TARGETING//RETROVIRAL ENTRY |
| 6 | 0.0000085045 | VPR//VPX//HIV 1 VPR |
| 7 | 0.0000084421 | ANTI R7V ANTIBODIES//C ADE//T CELL INFECTION |
| 8 | 0.0000080523 | NEF//HIV 1 NEF//HIV NEF |
| 9 | 0.0000076428 | UF SIDA//KODECYTE//ESA CNRS 6033 |
| 10 | 0.0000072299 | HIV 1 PROTEASE//HIV PROTEASE//KNI 272 |